Tumor progression inhibits the induction of multifunctionality in adoptively transferred tumor‐specific CD8+ T cells

No abstract is available for this paper.

• Publication year

  2009

• Venue

  European Journal of Immunology

• Publication date

  2009-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/eji.200838824PMID 19089817
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Frontline : Polyfunctional T cell responses are a hallmark of HIV-2 infection

  2008cited by this paper
• Dominance of CD4+ lymphocytic infiltrates with disturbed effector cell characteristics in the tumor microenvironment of prostate carcinoma

  2008cited by this paper
• Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness

  2008cited by this paper
• Principles of adoptive T cell cancer therapy.

  2007cited by this paper
• Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

  2007cited by this paper
• Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populations

  2007cited by this paper
• Immunization with vaccinia virus induces polyfunctional and phenotypically distinctive CD8+ T cell responses

  2007cited by this paper
• Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major

  2007cited by this paper
• Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

  2007cited by this paper
• Regulatory T cells, tumour immunity and immunotherapy

  2006cited by this paper
• Human T cell responses against melanoma.

  2006cited by this paper
• Adoptive immunotherapy for cancer: building on success

  2006cited by this paper
• HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

  2006cited by this paper
• Regulatory T cells

  2006cited by this paper
• Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation

  2006cited by this paper
• Toward improved immunocompetence of adoptively transferred CD8+ T cells.

  2005cited by this paper
• Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers

  2005cited by this paper
• Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

  2005cited by this paper
• CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cells

  2005cited by this paper
• Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance

  2005cited by this paper
• Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells.

  2005cited by this paper
• Interleukin-7-dependent expansion and persistence of melanoma-specific T cells in lymphodepleted mice lead to tumor regression and editing.

  2005cited by this paper
• Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

  2005cited by this paper
• Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts.

  2005cited by this paper
• Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells

  2005cited by this paper
• Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma.

  2005cited by this paper
• Cancer Immunotherapy: A Treatment for the Masses

  2004cited by this paper
• Seventeen-colour flow cytometry: unravelling the immune system

  2004cited by this paper
• Mini‐review: Overcoming tumor‐intrinsic resistance to immune effector function

  2004cited by this paper
• The three Es of cancer immunoediting.

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance.

  2004cited by this paper
• Expression of TNFα by CD3+ and F4/80+ cells following irradiation preconditioning and allogeneic spleen cell transplantation

  2004cited by this paper
• Of Mice and Not Men: Differences between Mouse and Human Immunology

  2004cited by this paper
• Persistent Toll-like receptor signals are required for reversal of regulatory T cell–mediated CD8 tolerance

  2004cited by this paper
• Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

  2004cited by this paper
• Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1

  2004cited by this paper
• Does the immune system see tumors as foreign or self?

  2003cited by this paper
• Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation.

  2003cited by this paper
• Natural selection of tumor variants in the generation of “tumor escape” phenotypes

  2002cited by this paper
• Antigens derived from melanocyte differentiation proteins: self‐tolerance, autoimmunity, and use for cancer immunotherapy

  2002cited by this paper
• Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

  2002cited by this paper
• Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease.

  2002cited by this paper
• Progress in human tumour immunology and immunotherapy

  2001cited by this paper
• Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

  2001cited by this paper
• IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

  2001cited by this paper
• Regulatory T cells in the control of immune pathology

  2001cited by this paper
• Topoisomerase I Inhibitors with an Indolocarbazole Structure Transporter as a Transporter of NB-506 and J-107088 , Resistance / Placenta-Specific , ATP-binding Cassette Identification of Breast Cancer Resistant Protein / Mitoxantrone Updated

  2001cited by this paper
• Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

  2001cited by this paper
• Regulatory T cells: key controllers of immunologic self-tolerance.

  2000cited by this paper
• Regulatory T cells in autoimmmunity*.

  2000cited by this paper
• T Cells Compete for Access to Antigen-Bearing Antigen-Presenting Cells

  2000cited by this paper
• Eradication of established tumors by CD8+ T cell adoptive immunotherapy.

  2000cited by this paper
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

  1999cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody.

  1999cited by this paper
• Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor α) monoclonal antibody

  1999cited by this paper
• Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.

  1999cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma.

  1997cited by this paper
• Tumor necrosis factor.

  1991cited by this paper
• Interferon gamma and tumor necrosis factor have a role in tumor regressions mediated by murine CD8+ tumor-infiltrating lymphocytes

  1991cited by this paper
• Tumor necrosis factor.

  1988cited by this paper
• Selection of highly transfectable variant from mouse mastocytoma P815

  1985cited by this paper
• Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

  1982cited by this paper
• Specificity of adoptive chemoimmunotherapy of established syngeneic tumors.

  1980cited by this paper

• The role of preoperative immunonutrition on morbidity and immune response after cystectomy: protocol of a multicenter randomized controlled trial (INCyst Trial)

  2024cites this paper
• Activated T cell therapy targeting glioblastoma cancer stem cells

  2023cites this paper
• Development of TCR-T cell therapy targeting mismatched HLA-DPB1 for relapsed leukemia after allogeneic transplantation

  2023cites this paper
• Tumor-Specific CD4+ T Cells Restrain Established Metastatic Melanoma by Developing Into Cytotoxic CD4– T Cells

  2022cites this paper
• Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement

  2021cites this paper
• Downregulation of ACE2 is associated with advanced pathological features and poor prognosis in clear cell renal cell carcinoma.

  2021cites this paper
• Infiltrating Immune Cells in Gastric Cancer: A Novel Predicting Model for Prognosis

  2021cites this paper
• Sequence of αPD-1 relative to local tumor irradiation determines the induction of abscopal antitumor immune responses

  2021cites this paper
• Edible Oxya chinensis sinuosa—Derived Protein as a Potential Nutraceutical for Anticancer Immunity Improvement

  2020cites this paper
• CD4+ T cells support polyfunctionality of cytotoxic CD8+ T cells with memory potential in immunological control of tumor

  2020cites this paper
• Quantifying the anti-tumor immune response in patients receiving immunotherapy.

  2017cites this paper
• Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

  2017cites this paper
• Can Be Determined by TCR Avidity, but Not Cytokine Polyfunctionality, T Cell + Influenza Epitope-Specific CD8

  2017cites this paper
• DGK-α: A Checkpoint in Cancer-Mediated Immuno-Inhibition and Target for Immunotherapy

  2017cites this paper
• IL-10 expression defines an immunosuppressive dendritic cell population induced by antitumor therapeutic vaccination

  2016cites this paper
• Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.

  2016cites this paper
• Generation of clinical-grade CD19-specific CAR-modified CD8+ memory stem cells for the treatment of human B-cell malignancies.

  2016cites this paper
• Foxp3 expression in CD4+CD25+Foxp3+ regulatory T cells promotes development of colorectal cancer by inhibiting tumor immunity

  2016cites this paper
• Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients.

  2016cites this paper
• Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells

  2016cites this paper
• αβ T-cell receptor bias in disease and therapy (Review).

  2016cites this paper
• Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer

  2015cites this paper
• Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes.

  2015cites this paper
• Differential Influence of Nutrient-Starved Mycobacterium tuberculosis on Adaptive Immunity Results in Progressive Tuberculosis Disease and Pathology

  2015cites this paper
• Cytotoxic T Lymphocytes Block Tumor Growth Both by Lytic Activity and IFNγ-Dependent Cell-Cycle Arrest

  2014cites this paper
• Manipulating Immune Regulatory Pathways to Enhance T Cell Stimulation

  2014cites this paper
• Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment

  2014cites this paper
• Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

  2014cites this paper
• Antitumor enhancement by adoptive transfer of tumor antigen primed, inactivated MHC-haploidentical lymphocytes.

  2014cites this paper
• Stimulation through very late antigen‐4 and ‐5 improves the multifunctionality and memory formation of CD8+ T cells

  2014cites this paper
• Immune Monitoring in Cancer Vaccine Clinical Trials: Critical Issues of Functional Flow Cytometry-Based Assays

  2013cites this paper
• Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation

  2012influential citation
• T‐cell receptor gene therapy targeting melanoma‐associated antigen‐A4 inhibits human tumor growth in non‐obese diabetic/SCID/γcnull mice

  2012cites this paper
• Tumor-Infiltrating CD 8 Cause Dysfunction of Human and Disabled MAPK Pathways α High DGK-Durner

  2012cites this paper
• What are regulatory T cells (Treg) regulating in cancer and why?

  2012influential citation
• CD25+ T cell depletion impairs murine squamous cell carcinoma development via modulation of antitumor immune responses.

  2012cites this paper
• Evaluating Cellular Polyfunctionality with a Novel Polyfunctionality Index

  2012cites this paper
• High DGK-α and Disabled MAPK Pathways Cause Dysfunction of Human Tumor-Infiltrating CD8+ T Cells That Is Reversible by Pharmacologic Intervention

  2012cites this paper
• Normalization of T cell receptor repertoire diversity in patients with advanced colorectal cancer who responded to chemotherapy

  2011cites this paper
• The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg).

  2011cites this paper
• Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine–prostaglandin E2 cooperation

  2011cites this paper
• Caractérisation de DKK1 comme antigène tumoral et manipulation des lymphocytes T CD8 : utilisation de la voie de Wnt en immunothérapie du cancer

  2011cites this paper
• Combination of lentivector immunization and low‐dose chemotherapy or PD‐1/PD‐L1 blocking primes self‐reactive T cells and induces anti‐tumor immunity

  2011cites this paper
• Adjuvant combination and antigen targeting as a strategy to induce polyfunctional and high-avidity T-cell responses against poorly immunogenic tumors.

  2011cites this paper
• Polyfunctionality of a DKK1 self-antigen-specific CD8+ T lymphocyte clone in lung cancer

  2011cites this paper
• Control of Disease Recurrence by Tumor-Infiltrating T Cells in Ovarian Cancer

  2010cites this paper
• JAK3/STAT5/6 Pathway Alterations Are Associated with Immune Deviation in CD8+ T Cells in Renal Cell Carcinoma Patients

  2010influential citation
• Polyfunctional T-Cell Responses Are Disrupted by the Ovarian Cancer Ascites Environment and Only Partially Restored by Clinically Relevant Cytokines

  2010cites this paper
• Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype.

  2010cites this paper
• Influenza Epitope-Specific CD8+ T Cell Avidity, but Not Cytokine Polyfunctionality, Can Be Determined by TCRβ Clonotype

  2010cites this paper
• Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals

  2010cites this paper
• Dynamic regulation of functionally distinct virus-specific T cells

  2010cites this paper
• Glucocorticoid‐induced tumor necrosis factor receptor stimulation enhances the multifunctionality of adoptively transferred tumor antigen‐specific CD8+ T cells with tumor regression

  2009cites this paper
• Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas.

  2009cites this paper